Dr. Reddy’s Laboratories announced the launch of over-the-counter (OTC) Lansoprazole delayed-release capsules, the generic version of Novartis’s Prevacid 24hr capsules. Prevacid received Rx-to-OTC switch (marketed under Takeda) approval from the FDA on March 18, 2009.
Lansoprazole is a proton pump inhibitor indicated for H. pylori eradication in duodenal ulcer disease, short-term treatment of active duodenal ulcer, active benign gastric ulcer, erosive esophagitis (EE), symptomatic GERD, and NSAID-associated gastric ulcers when NSAID use is continued. In addition, it is indicated for the maintenance of healing of duodenal ulcer, EE, and long-term treatment of pathological hypersecretory conditions (eg, Zollinger-Ellison syndrome).
Dr. Reddy’s Lansoprazole is available in 15mg dosage strength delayed-release capsules in 14-, 28-, and 42-count packs.
For more information call (908) 203-4933 or visit www.drreddys.com.